We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metabolic signature of <sup>13</sup>C-labeled wheat bran consumption related to gut fermentation in humans: a pilot study.
- Authors
Meiller, Laure; Sauvinet, Valérie; Breyton, Anne-Esther; Ranaivo, Harimalala; Machon, Christelle; Mialon, Anne; Meynier, Alexandra; Bischoff, Stephan C.; Walter, Jens; Neyrinck, Audrey M.; Laville, Martine; Delzenne, Nathalie M.; Vinoy, Sophie; Nazare, Julie-Anne
- Abstract
Purpose: The aim of this pilot study was to analyze concomitantly the kinetics of production of 13C-labeled gut-derived metabolites from 13C-labeled wheat bran in three biological matrices (breath, plasma, stools), in order to assess differential fermentation profiles among subjects. Methods: Six healthy women consumed a controlled breakfast containing 13C-labeled wheat bran biscuits. H2, CH4 and 13CO2, 13CH4 24 h-concentrations in breath were measured, respectively, by gas chromatography (GC) and GC-isotope ratio mass spectrometry (GC-IRMS). Plasma and fecal concentrations of 13C-short-chain fatty acids (linear SCFAs: acetate, propionate, butyrate, valerate; branched SCFAs: isobutyrate, isovalerate) were quantified using GC-combustion-IRMS. Gut microbiota composition was assessed by16S rRNA gene sequencing analysis. Results: H2 and CH4 24 h-kinetics distinguished two groups in terms of fermentation-related gas excretion: high-CH4 producers vs low-CH4 producers (fasting concentrations: 45.3 ± 13.6 ppm vs 6.5 ± 3.6 ppm). Expired 13CH4 was enhanced and prolonged in high-CH4 producers compared to low-CH4 producers. The proportion of plasma and stool 13C-butyrate tended to be higher in low-CH4 producers, and inversely for 13C-acetate. Plasma branched SCFAs revealed different kinetics of apparition compared to linear SCFAs. Conclusion: This pilot study allowed to consider novel procedures for the development of biomarkers revealing dietary fiber-gut microbiota interactions. The non-invasive assessment of exhaled gas following 13C-labeled fibers ingestion enabled to decipher distinct fermentation profiles: high-CH4 producers vs low-CH4 producers. The isotope labeling permits a specific in vivo characterisation of the dietary fiber impact consumption on microbiota metabolite production. Clinical trial registration: The study has been registered under the number NCT03717311 at ClinicalTrials.gov on October 24, 2018.
- Subjects
DIETARY fiber; PILOT projects; GUT microbiome; RNA; DYNAMICS; GAS chromatography; GENE expression; MASS spectrometry; BREAKFASTS; WHEAT; FERMENTATION; METABOLITES; SHORT-chain fatty acids; BUTYRIC acid
- Publication
European Journal of Nutrition, 2023, Vol 62, Issue 6, p2633
- ISSN
1436-6207
- Publication type
Article
- DOI
10.1007/s00394-023-03161-5